Adrenomedullin signaling is necessary for murine lymphatic vascular development

Journal of Clinical Investigation

Volumn 118, Issue 1, 2008, Pages 40-50

  Fritz Six, Kimberly L ^a   Dunworth, William P ^b   Li, Manyu ^a   Caron, Kathleen M ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; CALCITONIN RECEPTOR LIKE RECEPTOR; RECEPTOR ACTIVITY MODIFYING PROTEIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; IMMUNOHISTOCHEMISTRY; INTERSTITIAL FLUID; LYMPH VESSEL; LYMPHANGIOGENESIS; LYMPHEDEMA; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TIGHT JUNCTION; VASCULARIZATION;

ADRENOMEDULLIN; ANIMALS; CELL PROLIFERATION; EMBRYO LOSS; EMBRYONIC DEVELOPMENT; ENDOTHELIAL CELLS; FEMALE; HOMEODOMAIN PROTEINS; HOMEOSTASIS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHATIC DISEASES; LYMPHATIC VESSELS; LYMPHEDEMA; MALE; MAP KINASE SIGNALING SYSTEM; MEMBRANE PROTEINS; MICE; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PHYSIOLOGIC; PREGNANCY; RECEPTORS, CALCITONIN; TUMOR SUPPRESSOR PROTEINS;

EID: 38149064606     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI33302     Document Type: Article

References (59)

1. Alitalo, K., Tammela, T., and Petrova, T.V. 2005. Lymphangiogenesis in development and human disease. Nature. 438:946-953.
2. Karkkainen, M.J., and Alitalo, K. 2002. Lymphatic endothelial regulation, lymphoedema, and lymph node metastasis. Semin. Cell Dev. Biol. 13:9-18.
3. Karkkainen, M.J., Makinen, T., and Alitalo, K. 2002. Lymphatic endothelium: a new frontier of metastasis research. Nat. Cell. Biol. 4:E2-E5.
4. Scavelli, C., Vacca, A., Di Pietro, G., Dammacco, F., and Ribatti, D. 2004. Crosstalk between angiogenesis and lymphangiogenesis in tumor progression. Leukemia. 18:1054-1058.
5. Skobe, M., et al. 2001. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat. Med. 7:192-198.
6. Cao, Y. 2005. Opinion: emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis. Nat. Rev. Cancer. 5:735-743.
7. Oliver, G., and Alitalo, K. 2005. The lymphatic vasculature: recent progress and paradigms. Annu. Rev. Cell Dev. Biol. 21:457-483.
8. Hong, Y.K., and Detmar, M. 2003. Prox1, master regulator of the lymphatic vasculature phenotype. Cell Tissue Res. 314:85-92.
9. Wigle, J.T., et al. 2002. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J. 21:1505-1513.
10. Wigle, J.T., and Oliver, G. 1999. Prox1 function is required for the development of the murine lymphatic system. Cell. 98:769-778.
11. Karkkainen, M.J., et al. 2004. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat. Immunol. 5:74-80.
12. Abtahian, F., et al. 2003. Regulation of blood and lymphatic vascular separation by signaling proteins SLP-76 and Syk. Science. 299:247-251.
13. Schacht, V., et al. 2003. T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBO J. 22:3546-3556.
14. Yuan, L., et al. 2002. Abnormal lymphatic vessel development in neuropilin 2 mutant mice. Development. 129:4797-4806.
15. Petrova, T.V., et al. 2004. Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis. Nat. Med. 10:974-981.
16. Shimoda, H., et al. 2007. Abnormal recruitment of periendothelial cells to lymphatic capillaries in digestive organs of angiopoietin-2-deficient mice. Cell Tissue Res. 328:329-337.
17. Yla-Herttuala, S., and Alitalo, K. 2003. Gene transfer as a tool to induce therapeutic vascular growth. Nat. Med. 9:694-701.
18. Tammela, T., Petrova, T.V., and Alitalo, K. 2005. Molecular lymphangiogenesis: new players. Trends Cell Biol. 15:434-441.
19. Zudaire, E., Martinez, A., and Cuttitta, F. 2003. Adrenomedullin and cancer. Regul. Pept. 112:175-183.
20. Gibbons, C., Dackor, R., Dunworth, W., Fritz-Six, K., and Caron, K.M. 2007. Receptor activity-modifying proteins: RAMPing up adrenomedullin signaling. Mol. Endocrinol. 21:783-796.
21. Zhou, M., Simms, H.H., and Wang, P. 2004. Adrenomedullin and adrenomedullin binding protein-1 attenuate vascular endothelial cell apoptosis in sepsis. Ann. Surg. 240:321-330.
22. Fernandez-Sauze, S., et al. 2004. Effects of adrenomedullin on endothelial cells in the multistep process of angiogenesis: involvement of CRLR/RAMP2 and CRLR/RAMP3 receptors. Int. J. Cancer. 108:797-804.
23. Kato, H., Shichiri, M., Marumo, F., and Hirata, Y. 1997. Adrenomedullin as an autocrine/paracrine apoptosis survival factor for rat endothelial cells. Endocrinology. 138:2615-2620.
24. Miyashita, K., et al. 2003. Adrenomedullin promotes proliferation and migration of cultured endothelial cells. Hypertens. Res. 26(Suppl.):S93-S98.
25. Kim, W., et al. 2003. Angiogenic role of adrenomedullin through activation of Akt, mitogen-activated protein kinase, and focal adhesion kinase in endothelial cells. FASEB J. 17:1937-1939.
26. Miyashita, K., et al. 2003. Adrenomedullin provokes endothelial Akt activation and promotes vascular regeneration both in vitro and in vivo. FEBS Lett. 544:86-92.
27. Iimuro, S., et al. 2004. Angiogenic effects of adrenomedullin in ischemia and tumor growth. Circ. Res. 95:415-423.
28. Yurugi-Kobayashi, T., et al. 2006. Adrenomedullin/cyclic AMP pathway induces Notch activation and differentiation of arterial endothelial cells from vascular progenitors. Arterioscler. Thromb. Vasc. Biol. 26:1977-1984.
29. McLatchie, L.M., et al. 1998. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature. 393:333-339.
30. Arulmani, U., Maassenvandenbrink, A., Villalon, C.M., and Saxena, P.R. 2004. Calcitonin gene-related peptide and its role in migraine pathophysiology. Eur. J. Pharmacol. 500:315-330.
31. Nagaya, N., Mori, H., Murakami, S., Kangawa, K., and Kitamura, S. 2005. Adrenomedullin: angiogenesis and gene therapy. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288:R1432-R1437.
32. Ishimitsu, T., Ono, H., Minami, J., and Matsuoka, H. 2006. Pathophysiologic and therapeutic implications of adrenomedullin in cardiovascular disorders. Pharmacol. Ther. 111:909-927.
33. Julian, M., et al. 2005. Adrenomedullin: a new target for the design of small molecule modulators with promising pharmacological activities. Eur. J. Med. Chem. 40:737-750.
34. Dackor, R., Fritz-Six, K., Smithies, O., and Caron, K. 2007. Receptor activity-modifying proteins 2 and 3 have distinct physiological functions from embryogenesis to old age. J. Biol. Chem. 282:18094-18099.
35. Caron, K.M., and Smithies, O. 2001. Extreme hydrops fetalis and cardiovascular abnormalities in mice lacking a functional Adrenomedullin gene. Proc. Natl. Acad. Sci. U. S. A. 98:615-619.
36. Dackor, R.T., et al. 2006. Hydrops fetalis, cardiovascular defects, and embryonic lethality in mice lacking the calcitonin receptor-like receptor gene. Mol. Cell. Biol. 26:2511-2518.
37. Koni, P.A., et al. 2001. Conditional vascular cell adhesion molecule 1 deletion in mice: impaired lymphocyte migration to bone marrow. J. Exp. Med. 193:741-754.
38. Hippenstiel, S., et al. 2002. Adrenomedullin reduces endothelial hyperpermeability. Circ. Res. 91:618-625.
39. Kis, B., et al. 2003. Chronic adrenomedullin treatment improves blood-brain barrier function but has no effects on expression of tight junction proteins. Acta. Neurochir. Suppl. 86:565-568.
40. Feng, Y., et al. 2006. Filamin A (FLNA) is required for cell-cell contact in vascular development and cardiac morphogenesis. Proc. Natl. Acad. Sci. U. S. A. 103:19836-19841.
41. Braren, R., et al. 2006. Endothelial FAK is essential for vascular network stability, cell survival, and lamellipodial formation. J. Cell Biol. 172:151-162.
42. Zwerts, F., et al. 2007. Lack of endothelial cell survivin causes embryonic defects in angiogenesis, cardiogenesis, and neural tube closure. Blood. 109:4742-4752.
43. Kim, K., et al. 2000. Polycystin 1 is required for the structural integrity of blood vessels. Proc. Natl. Acad. Sci. U. S. A. 97:1731-1736.
44. Sharpe, J., et al. 2002. Optical projection tomography as a tool for 3D microscopy and gene expression studies. Science. 296:541-545.
45. Hay, D.L., et al. 2003. CL/RAMP2 and CL/RAMP3 produce pharmacologically distinct adrenomedullin receptors: a comparison of effects of adrenomedullin22-52, CGRP8-37 and BIBN4096BS. Br. J. Pharmacol. 140:477-486.
46. Petrova, T.V., et al. 2002. Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. EMBO J. 21:4593-4599.
47. Hirakawa, S., et al. 2003. Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells. Am. J. Pathol. 162:575-586.
48. Tabibiazar, R., Cheet al. 2006. Inflammatory Manifestations of Experimental Lymphatic Insufficiency. PLoS Med. 3:e254.
49. Doods, H., et al. 2000. Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist. Br. J. Pharmacol. 129:420-423.
50. Doods, H. 2001. Development of CGRP antagonists for the treatment of migraine. Curr. Opin. Investig. Drugs. 2:1261-1268.
51. Ribatti, D., Nico, B., Spinazzi, R., Vacca, A., and Nussdorfer, G.G. 2005. The role of adrenomedullin in angiogenesis. Peptides. 26:1670-1675.
52. Morisada, T., et al. 2005. Angiopoietin-1 promotes LYVE-1-positive lymphatic vessel formation. Blood. 105:4649-4656.
53. Harzenetter, M.D., et al. 2002. Regulation and function of the CGRP receptor complex in human granulopoiesis. Exp. Hematol. 30:306-312.
54. Del Pup, L., et al. 2003. Adrenomedullin is expressed in cord blood hematopoietic cells and stimulates their clonal growth. Int J Mol Med 11:157-160.
55. Sebzda, E., et al. 2006. Syk and Slp-76 mutant mice reveal a cell-autonomous hematopoietic cell contribution to vascular development. Dev. Cell. 11:349-361.
56. Taniguchi, K., et al. 2007. Spreds are essential for embryonic lymphangiogenesis by regulating vascular endothelial growth factor receptor-3 signaling. Mol. Cell. Biol. 27:4541-4550.
57. Witte, M.H., Bernas, M.J., Martin, C.P., and Witte, C.L. 2001. Lymphangiogenesis and lymphangiodysplasia: from molecular to clinical lymphology. Microsc. Res. Tech. 55:122-145.
58. Nakagami, H., et al. 2005. Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells. Arterioscler. Thromb. Vasc. Biol. 25:2542-2547.
59. Steffensen, K.R., et al. 2004. Functional conservation of interactions between a homeodomain cofactor and a mammalian FTZ-F1 homologue. EMBO Rep. 5:613-619.